167357-55-3 Usage
Description
(+)-2(S)-(phenylmethyloxymethyl)morpholine, also known as PMOM, is a chiral morpholine derivative with a phenylmethyl group attached to the oxygen atom. It is a versatile chemical compound commonly used as a chiral building block in organic synthesis.
Uses
Used in Pharmaceutical Industry:
(+)-2(S)-(phenylmethyloxymethyl)morpholine is used as a chiral building block for the synthesis of various drugs with therapeutic properties. Its ability to introduce chirality into organic compounds makes it a valuable tool in drug discovery and development.
Used in Organic Synthesis:
(+)-2(S)-(phenylmethyloxymethyl)morpholine is used as a reagent in the preparation of chiral intermediates and natural products, contributing to the advancement of organic chemistry and the creation of enantioselective synthetic routes.
Check Digit Verification of cas no
The CAS Registry Mumber 167357-55-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,7,3,5 and 7 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 167357-55:
(8*1)+(7*6)+(6*7)+(5*3)+(4*5)+(3*7)+(2*5)+(1*5)=163
163 % 10 = 3
So 167357-55-3 is a valid CAS Registry Number.
167357-55-3Relevant articles and documents
BENZAMIDE DERIVATIVES, THEIR PREPARATION AND USES IN MEDICINE THEREOF
-
Page/Page column 13-14, (2010/06/15)
The present invention discloses novel benzamide derivatives represented by general formula (I), their preparation, pharmaceutical compositions containing the derivatives and their use as medicament, especially as a 5-HT4 stimulator, wherein the
CYSTEINE PROTEASE INHIBITORS
-
Page/Page column 34-35, (2008/06/13)
Stereoisomers of the formula (III) wherein R is H or C1-C3 optionally halo-substituted alkyl; or pharmaceutically acceptable salts, hydrates or N-oxides thereof have utility in the treatment of disorders mediated by inappropriate exp
HETEROARYL UREA DERIVATIVES USEFUL FOR INHIBITING CHKl
-
Page/Page column 74; 75, (2008/06/13)
Substituted urea compounds useful in the treatment of diseases and conditions related to DNA damage or lesions in DNA replication are disclosed. Methods of making the compounds, and their use as therapeutic agents, for example, in treating cancer and other diseases characterized by defects in DNA replication, chromosome segregation, or cell division, also are disclosed.
